Table 4.
Characteristic | Number (%) |
---|---|
Sex (M/F) | 4/7 (36%/64%) |
Age (mean ± SD) | 53 ± 14 (range from 19 to 71) |
SSc duration (mean ± SD in yrs); 9 pts | 4.49 ± 3.37 (range from 0.42 to 10 yrs) |
SSc Dx to AAV dx (mean ± SD in yrs); 10 pts | 3.85 ± 2.67 (range from 0.42 to 8 yrs) |
SSc type (Diffuse/Limited) | 7/3 (64%/27%) |
D-penicillamine use | 4 (36%) |
Renal involvement | 9 (82%) all with crescentic GN on Bx |
Pulmonary involvement | 2 (18%) |
ANA + (>1 : 320) | 8 (88%) |
Scl-70 + | 5 (45%) |
Anticentromere + | 1 (9%) |
MPO + | 10 (91%) |
PR3 + | 0 |